A
Alpha Tau Medical Ltd. (DRTS)
6.86
0.00 (0.00%)
Get all premium features to the best stock analysis tool
6.86
0.00 (0.00%)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
| Name | Position |
|---|---|
| Dr. Robert B. Den M.D. | Chief Medical Officer & Member of Scientific Advisory Board |
| Mr. Amnon Gat | Chief Operations Officer |
| Mr. Raphi Levy | Chief Financial Officer |
| Mr. Ronen Segal | Chief Technology Officer |
| Mr. Uzi Sofer | CEO & Chairman |
| Ms. Rebecca Becker | Vice President of legal |
| Ms. Yael Zeiger | Corporate Controller |
| Prof. Yona Keisari |
| Date | Type | Document |
|---|---|---|
| 2026-03-09 | 20-F | ea0279271-20f_alpha.htm |
| 2026-01-29 | 6-K | ea0274527-6k_alpha.htm |
| 2026-01-06 | 6-K | ea027162401-6k_alpha.htm |
| 2026-01-05 | 6-K | ea027162402-6k_alpha.htm |
| 2025-12-18 | 6-K | ea0270145-6k_alpha.htm |
| 2025-12-09 | 6-K | ea0268912-6k_alpha.htm |
| 2025-12-04 | 6-K | ea0268426-6k_alpha.htm |
| 2025-12-02 | 6-K | ea026791901-6k_alphatau.htm |
| 2025-11-20 | 6-K | ea0265910-6k_alpha.htm |
| 2025-10-21 | 6-K | ea0261885-6k_alpha.htm |
| Chief Scientific Officer & Member of Scientific Advisory board |